- Investing Ideas
- /
- U.S. Potentially Undervalued Companies
U.S. Potentially Undervalued Companies
Results
6329
0 new
Companies with a Value score of at least 3, ordered by Value score
6,329 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
HKUO.Y | JP¥17.20 | -0.06% | n/a | JP¥454.5b | JP¥16.97 | PE17.5x | E6.8% | 2.6% | Media | ||
PLYA | US$7.84 | -2.0% | 7.3% | US$1.0b | US$10.50 | PE17.5x | E11.0% | n/a | Consumer Services | ||
AILE | US$1.70 | 23.2% | -83.8% | US$242.8m | US$19.50 | PB82.1x | S20.8% | n/a | Software | ||
FSNU.F | €37.35 | 0.7% | n/a | €18.8b | €44.04 | PE26.1x | E23.7% | n/a | Healthcare | ||
BRLX.F | CA$26.92 | 5.7% | 13.7% | CA$3.6b | CA$31.23 | PE39.1x | E16.7% | 1.8% | Utilities | ||
MNDO | US$1.98 | -0.5% | 5.3% | US$40.6m | n/a | PE7.8x | n/a | 12.1% | Software | ||
PNFP | US$96.47 | -4.1% | 46.9% | US$7.3b | US$104.25 | PB1.2x | E28.0% | 0.9% | Banks | ||
AIRS | US$5.59 | 18.2% | -14.8% | US$312.1m | US$3.38 | PS1.7x | E121.0% | n/a | Healthcare | ||
HWM | US$99.30 | 1.9% | 113.6% | US$40.7b | US$103.00 | PE43.5x | E16.5% | 0.3% | Capital Goods | ||
AMSW.A | US$10.95 | 0.3% | -4.6% | US$367.2m | US$16.00 | PE40.4x | E2.4% | 4.0% | Software | ||
HOPE | US$12.42 | -6.0% | 43.1% | US$1.5b | US$13.60 | PB0.7x | E25.8% | 4.5% | Banks | ||
WLDB.F | CA$0.96 | 1.1% | -15.0% | CA$263.9m | CA$1.41 | PE-2.6x | E120.8% | 0% | Media | ||
E | €30.19 | -5.8% | -7.0% | €43.1b | €37.60 | PE11.1x | E11.0% | 6.9% | Energy | ||
PRTS | US$0.90 | 1.6% | -77.8% | US$50.5m | US$1.65 | PB0.5x | E6.8% | n/a | Retail | ||
SCRY.Y | €2.27 | 5.8% | -26.9% | €3.7b | €2.86 | PE18.5x | E34.5% | 8.8% | Insurance | ||
RGEN | US$147.18 | 1.0% | -8.1% | US$7.8b | US$193.82 | PS13.7x | E85.3% | n/a | Pharmaceuticals & Biotech | ||
AMSC | US$22.06 | 0.7% | 194.1% | US$924.5m | US$30.33 | PS5.6x | E105.0% | n/a | Capital Goods | ||
EWCZ | US$6.98 | -5.4% | -57.4% | US$403.7m | US$8.69 | PE26.4x | E27.6% | n/a | Consumer Services | ||
IRT | US$20.52 | -2.8% | 45.8% | US$4.8b | US$20.95 | PB1.4x | E66.6% | 3.1% | Real Estate | ||
LOW | US$265.61 | 1.8% | 27.8% | US$150.3b | US$258.64 | PE21.8x | E4.6% | 1.7% | Retail | ||
PRAX | US$57.79 | -8.3% | 133.5% | US$1.0b | US$146.44 | PS579.4x | E19.2% | n/a | Pharmaceuticals & Biotech | ||
LGND | US$99.38 | -5.4% | 61.6% | US$1.8b | US$124.00 | PE43.1x | E25.6% | n/a | Pharmaceuticals & Biotech | ||
ROSE.U | US$11.74 | 0% | 10.0% | US$61.7m | n/a | PE15.7x | n/a | n/a | Diversified Financials | ||
REVN.F | €20.51 | 0% | n/a | €4.1b | n/a | PE17.7x | S55.5% | 1.3% | Diversified Financials |